48 research outputs found
Recommended from our members
Medical application of in vivo neutron activation analysis
The clinical usefulness of total body neutron activation analysis (TBNAA) was clearly established at an IAEA panel meeting in Vienna in 1972. It is best demonstrated by the studies involving the measurement of total-body calcium. This measurement provides data useful for the diagnosis and management of metabolic bone disorders. It should be emphasized, however, that while most of the applications to date have involved calcium and phosphorus, the measurement of sodium, chlorine and nitrogen also appear to be useful clinically. Total-body calcium measurements utilizing TBNAA have been used in studies of osteoporosis to establish absolute and relative deficits of calcium in patients with this disease in comparison to a normal contrast population. Changes in total-body calcium (skeletal mass) have also been useful for quantitating the efficacy of various therapies in osteoporosis. Serial measurements over periods of years provide long-term balance data by direct measurement with a higher precision (+- 2%) than is possible by the use of any other technique. In the renal osteodystrophy observed in patients with renal failure, disorders of both calcium and phosphorus, as well as electrolyte disturbances, have been studied. The measure of total-body levels of these elements gives the clinician useful data upon which to design dialysis therapy. The measurement of bone changes in endocrine dysfunction has been studied, particularly in patients with thyroid and parathyroid disorders. In parathyroidectomy, the measurement of total-body calcium, post-operatively, can indicate the degree of bone resorption. Skeletal metabolism and body composition in acromegaly and Cushing's disease have also been investigated by TBNAA. Levels of cadmium in liver and kidney have also been measured in-vivo by prompt-gamma neutron activation and associated with hypertension, emphysema and cigarette smoking
Recommended from our members
Age- and sex-related changes in bone mass measured by neutron activation
Total-body calcium (TBCa) measurements have been employed in two basic types of studies. In the first type, serial measurements made on an individual patient are used to trace the time variation in body calcium. In the second type of study, the absolute total body calcium of an individual is determined and compared to a standard or predicted value in order to determine the deficit or excess of calcium. Generally, the standards are derived from data obtained from normal populations and grouped by the parameters of age and sex (mean value denoted TBCa/sub m/). In the study reported in this paper, the clinical usefulness of predicted calcium (TBCa/sub p/) is evaluated. The predicted value (TBCa/sub p/) for an individual is obtained with an algorithm utilizing values of sex and age, height and lean body mass (as derived from /sup 40/K measurement). The latter two components characterize skeletal size and body habitus, respectively. For the study, 133 white women and 71 white men ranging in age from 20 to 80 years were selected from a larger population. Individuals with evidence of metabolic calcium disorders or osteoporosis were excluded. Additionally, the women and men selected were first judged to have total body potassium levels in the normal range. For each age decade, the variance of TBCa values of these individuals, when expressed in terms of TBCa/sub p/, was significantly less than when expressed in terms of TBCa/sub m/. Thus, erroneous conclusions based on Ca deficit in osteoporosis could be drawn for individuals whose height and body size differ markedly from the average, as the variation of their TBCa values often exceeds the variation in the age and sex cohort. Data on a group of osteoporotic women were compared with the normal skeletal baseline values both in terms of the TBCa and the TBCa/sub p/ values